Supplier
Alivia Infusion Services LLC
Alivia Infusion Services LLC was paid $10.93M by Medicaid between Jan 2018 and Oct 2024, across 10 billing codes. Its largest line is 96365, Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour — 41% of everything it billed.
33Billing provider infoALIVIA INFUSION SERVICES LLC
PONCE, PR 00728
PONCE, PR 00728
33aNPI1881915031assigned 06/22/2010
33bProvider typePharmacy
28Total paid$10.93M
24GClaims15,169
24DCodes billed10
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Pharmacy providers in Puerto Rico
Rank by total paid#1 of 10
Median peer was paid$4K
This provider vs. median3,012×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,249 | $919K | |
| 2019 | 1,533 | $1.12M | |
| 2020 | 1,983 | $1.49M | |
| 2021 | 2,937 | $2.28M | |
| 2022 | 2,040 | $2.18M | |
| 2023 | 3,851 | $2.12M | |
| 2024incomplete | 1,576 | $821K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 41% | 5,540 | 3,124 | $4.51M |
| S9430 | Pharmacy compounding and dispensing services | 17% | 2,380 | 2,167 | $1.82M |
| S9494 | Home infusion therapy, antibiotic, antiviral, or antifungal therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with home infusion codes for hourly dosing schedules s9497-s9504) | 17% | 1,899 | 1,801 | $1.82M |
| J0878 | Injection, daptomycin, 1 mg | 9.9% | 754 | 422 | $1.08M |
| J1335 | Injection, ertapenem sodium, 500 mg | 8.2% | 1,448 | 1,022 | $897K |
| J2185 | Injection, meropenem, 100 mg | 2.8% | 548 | 318 | $310K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1.4% | 839 | 616 | $156K |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 1.4% | 992 | 560 | $154K |
| J3370 | Injection, vancomycin hcl, 500 mg | 1.2% | 656 | 465 | $136K |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 113 | 70 | $36K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSABNANI, HARI (PRESIDENT & CEO)
| Provider | Location | Paid |
|---|---|---|
| Alivia Specialty, LLC | Guaynabo, PR | $188.98M |
| Plaza Health LLC | Bayamon, PR | $3K |
| Plaza Health LLC | Toa Baja, PR | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.